Edmond de Rothschild (Suisse)’s Theriva Biologics TOVX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	$499K	Buy	33 +1	+3%	+$15.1K	0.15%	132
2016 Q2	$504K	Buy	32 +6	+23%	+$94.5K	0.17%	117
2016 Q1	$543K	Buy	26 +9	+53%	+$188K	0.22%	97
2015 Q4	$344K	Hold	17	–	–	0.13%	108
2015 Q3	$340K	Buy	+17	New	+$340K	0.11%	116